Automation and artificial intelligence are changing how scientists design, test and refine new molecules. At the University ...

As we step into 2026, the AI and analytics story for health care and life sciences isn’t about sudden disruption – it’s about ...

Myriad Genetics has grown from a mainly Hereditary Cancer business into a broader precision medicine company. Click here to ...

Merck & Co. will apply the somatic genomics platform Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 ...

In an R&D collaboration worth as much as $838 million, Merck will lean on Infinimmune to discover immune cell-directed ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among ...

A massive genetic analysis of more than 6 million people is revealing new clues about why mental health disorders frequently overlap.

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

Researchers confirmed a four-biomarker model is more informative at younger vs older ages, with slight sex differences.

Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...